Technical Study: Quest Diagnostics Inc., Santarus Inc., Isis Pharma Inc., and Community Health Systems Inc.
LONDON, November 1, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
The U.S. equity market closed on a negative note on Thursday, October 31, 2013, with the S&P 500, the Dow Jones Industrial Average and the NASDAQ Composite declining 0.38%, 0.47%, and 0.28%, respectively. Shares in the healthcare sector mostly ended on a positive note, even as the broader market posted losses. Quest Diagnostics Inc. (NYSE: DGX), Santarus Inc. (NASDAQ: SNTS), Isis Pharmaceuticals Inc. (NASDAQ: ISIS), and Community Health Systems Inc. (NYSE: CYH), were amongst the major movers from the sector during the trading session. AAAResearchReports.com free coverage on DGX, SNTS, ISIS, and CYH is available upon registration at:
Quest Diagnostics Inc.'s stock gained 0.44% on Thursday, even as the broader market finished on a negative note. The company's stock closed at $59.91 after oscillating between $59.58 and $60.04 during the trading session. A total of 1.52 million shares were traded, which is above the daily average volume of 1.45 million. The company's shares have gained 1.63% in the previous three trading sessions, outperforming the S&P 500, which has lost 0.32% during the same period. Additionally, Quest Diagnostics Inc.'s stock is trading above its 200-day moving average of $59.09. Download free technical research on DGX by signing up at:
On Thursday, Santarus Inc.'s stock ended the session 0.82% higher than the previous day's price of $23.14. The company's shares oscillated between $22.66 and $23.60 before closing the day at $23.33. A total of 1.54 million shares were traded, which is below the daily average volume of 1.80 million. The company's shares have advanced 3.28% in the previous one month, underperforming the S&P 500, which has gained 4.46% during the same period. Moreover, Santarus Inc.'s stock is trading above its 50-day and 200-day moving averages of $22.79 and $20.13, respectively. Register now and get access to free analysis on SNTS at:
Isis Pharmaceuticals Inc.'s stock plummeted 2.78% on Thursday, tracking losses in the broader market. The company's shares ended the day at $33.27 after fluctuating between $33.02 and $34.63 during the trading session. A total of 1.14 million shares were traded, which is below the daily average volume of 1.45 million. Despite Thursday's decline, the company's shares have gained 15.32% in the previous three months, outperforming the S&P 500 which has gained 4.20% during the same period. Further, Isis Pharmaceuticals Inc.'s stock is trading above its 50-day and 200-day moving averages of $32.42 and $24.00, respectively. Sign up and read our complimentary report on ISIS at:
Community Health Systems Inc.'s stock rose 1.84% on Thursday, closing at $43.63, after fluctuating between $43.43 and $46.15 during the trading session. A total of 3.55 million shares were traded, which is above the daily average volume of 1.74 million. The company's shares have advanced 5.13% in the previous one month and 2.88% in the last three trading sessions, compared to a gain of 4.46% and a loss of 0.32% in the S&P 500 during the respective periods. Furthermore, Community Health Systems Inc.'s stock is trading above its 50-day and 200-day moving averages of $41.49 and $43.40, respectively. The free report on CYH can be downloaded by signing up now at:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to making mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
- For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE AAA Research Reports